ATE449177T1 - Staphylococcus epidermidis antigene - Google Patents

Staphylococcus epidermidis antigene

Info

Publication number: ATE449177T1
Authority: AT; Austria
Prior art keywords: antigens; staphylococcus epidermidis; epidermidis antigens; hyperimmune serum; serum reactive
Prior art date: 2003-03-31

Application number

AT04724557T

Other languages

English (en)

Inventor

Andreas Meinke

Bui Duc Min

Eszter Nagy

Original Assignee

Intercell Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-31

Filing date

2004-03-31

Publication date

2009-12-15

2004-03-31 Application filed by Intercell Ag filed Critical Intercell Ag

2009-12-15 Application granted granted Critical

2009-12-15 Publication of ATE449177T1 publication Critical patent/ATE449177T1/de

Links

239000000427 antigen Substances 0.000 title abstract 4
102000036639 antigens Human genes 0.000 title abstract 4
108091007433 antigens Proteins 0.000 title abstract 4
241000191963 Staphylococcus epidermidis Species 0.000 title abstract 2
239000012634 fragment Substances 0.000 abstract 2
230000000521 hyperimmunizing effect Effects 0.000 abstract 2
210000002966 serum Anatomy 0.000 abstract 2
150000007523 nucleic acids Chemical class 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Materials For Medical Uses (AREA)

AT04724557T 2003-03-31 2004-03-31 Staphylococcus epidermidis antigene ATE449177T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03450078		2003-03-31
PCT/EP2004/003398 WO2004087746A2 (en)	2003-03-31	2004-03-31	Staphylococcus epidermidis antigens

Publications (1)

Publication Number	Publication Date
ATE449177T1 true ATE449177T1 (de)	2009-12-15

Family

ID=33104246

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04724557T ATE449177T1 (de)	2003-03-31	2004-03-31	Staphylococcus epidermidis antigene

Country Status (8)

Country	Link
US (4)	US7628994B2 (de)
EP (2)	EP1608756B1 (de)
JP (1)	JP2007523609A (de)
AT (1)	ATE449177T1 (de)
AU (1)	AU2004226262A1 (de)
CA (1)	CA2520868A1 (de)
DE (1)	DE602004024179D1 (de)
WO (1)	WO2004087746A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2004226262A1 (en)	2003-03-31	2004-10-14	Intercell Ag	Staphylococcus epidermidis antigens
WO2005005630A2 (en) *	2003-07-08	2005-01-20	Umc Utrecht Holding B.V.	Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases
BRPI0516974A (pt) *	2004-10-21	2008-09-30	Wyeth Corp	composição imunogênica compreendendo um polipeptìdeo; um método para induzir uma resposta imune contra staphylococcus epidermidis; um método para induzir uma resposta imune contra staphylococcus aureus; um método para a detecção e/ou identificação de staphylococcus epidermidis; um método para a detecção e/ou identificação de anticorpos para staphylococcus epidermidis
MX2007015758A (es) *	2005-06-13	2008-02-22	Nabi Biopharmaceuticals	Uso de leucocidina de panton-valentine para tratar y prevenir infecciones por estafilococos.
CN101610781A (zh)	2007-01-24	2009-12-23	默克公司	用于诱导针对表皮葡萄球菌的保护性免疫应答的多肽
EP1980269A1 (de) *	2007-04-13	2008-10-15	Katholieke Universiteit Leuven	Prävention von Staphylokokken-Biofilmbildung
AU2010264538B2 (en)	2009-06-22	2013-10-03	Wyeth Llc	Immunogenic compositions of Staphylococcus aureus antigens
WO2013184900A2 (en) *	2012-06-06	2013-12-12	Sanofi Pasteur Biologics, Llc	Immunogenic compositions and related methods
ITNA20120046A1 (it)	2012-08-02	2014-02-03	No Self S R L	Uso di acidi nucleici di sistemi biologici parassiti, patogeni e infestanti per l'inibizione e/o controllo degli stessi sistemi
NL2022581B1 (en) *	2019-02-14	2020-08-27	Koppert Bv	Composition comprising a mixture of dna molecules, uses thereof as biological inhibitor and method for production

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4946778A (en)	1987-09-21	1990-08-07	Genex Corporation	Single polypeptide chain binding molecules
ATE318832T1 (de)	1990-06-11	2006-03-15	Gilead Sciences Inc	Verfahren zur vervendung von nukleinsäureliganden
AU713040B2 (en)	1994-07-15	1999-11-18	University Of Iowa Research Foundation, The	Immunomodulatory oligonucleotides
CO4600681A1 (es)	1996-02-24	1998-05-08	Boehringer Ingelheim Pharma	Composicion farmaceutica para la modulacion inmunitaria
ES2188985T3 (es)	1996-08-30	2003-07-01	Jens Peter Furste	Seleccion enantiomerica y evolucion enantiomerica de acidos nucleicos.
US5989912A (en)	1996-11-21	1999-11-23	Oligos Etc. Inc.	Three component chimeric antisense oligonucleotides
US5849902A (en)	1996-09-26	1998-12-15	Oligos Etc. Inc.	Three component chimeric antisense oligonucleotides
US6380370B1 (en) *	1997-08-14	2002-04-30	Genome Therapeutics Corporation	Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
DE19742706B4 (de)	1997-09-26	2013-07-25	Pieris Proteolab Ag	Lipocalinmuteine
DE19803453A1 (de)	1998-01-30	1999-08-12	Boehringer Ingelheim Int	Vakzine
AT408721B (de)	1999-10-01	2002-02-25	Cistem Biotechnologies Gmbh	Pharmazeutische zusammensetzung enthaltend ein antigen
PT2275551E (pt) *	1999-10-29	2015-06-29	Novartis Vaccines & Diagnostic	Péptidos antigénicos de neisseria
AU1478301A (en) *	1999-11-09	2001-06-06	Glaxo Group Limited	Staphylococcus epidermidis nucleic acids and proteins
AT409085B (de)	2000-01-28	2002-05-27	Cistem Biotechnologies Gmbh	Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
EP1272215B1 (de)	2000-04-14	2007-10-10	Intercell AG	Modifizierte peptide enthaltende pharmazeutische präparationen
HU228264B1 (en)	2000-06-08	2013-02-28	Intercell Ag	Immunostimulatory oligodeoxynucleotides
AT410173B (de)	2000-06-08	2003-02-25	Cistem Biotechnologies Gmbh	Antigene zusammensetzung
AU2001289813B2 (en)	2000-08-17	2005-07-28	Intercell Ag	A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof
JP4097178B2 (ja) *	2000-10-03	2008-06-11	株式会社グリーンペプタイド	腫瘍抗原
AT410635B (de)	2000-10-18	2003-06-25	Cistem Biotechnologies Gmbh	Vakzin-zusammensetzung
AT410798B (de) *	2001-01-26	2003-07-25	Cistem Biotechnologies Gmbh	Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
AU2002306849A1 (en) *	2001-03-21	2002-10-08	Elitra Pharmaceuticals, Inc.	Identification of essential genes in microorganisms
EP1412379B1 (de) *	2001-08-02	2012-01-25	The University Of Sheffield	Impfstoff
WO2004025416A2 (en) *	2002-09-13	2004-03-25	The Texas A & M University System	Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
AU2004226262A1 (en)	2003-03-31	2004-10-14	Intercell Ag	Staphylococcus epidermidis antigens

2004
- 2004-03-31 AU AU2004226262A patent/AU2004226262A1/en not_active Abandoned
- 2004-03-31 US US10/551,492 patent/US7628994B2/en not_active Expired - Fee Related
- 2004-03-31 WO PCT/EP2004/003398 patent/WO2004087746A2/en not_active Ceased
- 2004-03-31 EP EP04724557A patent/EP1608756B1/de not_active Expired - Lifetime
- 2004-03-31 JP JP2006504930A patent/JP2007523609A/ja not_active Withdrawn
- 2004-03-31 EP EP09173794A patent/EP2182065A3/de not_active Ceased
- 2004-03-31 DE DE602004024179T patent/DE602004024179D1/de not_active Expired - Lifetime
- 2004-03-31 CA CA002520868A patent/CA2520868A1/en not_active Abandoned
- 2004-03-31 AT AT04724557T patent/ATE449177T1/de not_active IP Right Cessation
2009
- 2009-11-24 US US12/625,053 patent/US8236325B2/en not_active Expired - Fee Related
2012
- 2012-07-03 US US13/540,696 patent/US8372410B2/en not_active Expired - Fee Related
2013
- 2013-01-09 US US13/737,228 patent/US20130122030A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US8236325B2 (en)	2012-08-07
CA2520868A1 (en)	2004-10-14
EP2182065A2 (de)	2010-05-05
DE602004024179D1 (de)	2009-12-31
EP1608756B1 (de)	2009-11-18
US20130122030A1 (en)	2013-05-16
EP1608756A2 (de)	2005-12-28
US20070036778A1 (en)	2007-02-15
WO2004087746A3 (en)	2005-04-21
US20100297162A1 (en)	2010-11-25
US7628994B2 (en)	2009-12-08
US8372410B2 (en)	2013-02-12
US20120269843A1 (en)	2012-10-25
EP2182065A3 (de)	2010-09-15
JP2007523609A (ja)	2007-08-23
WO2004087746A2 (en)	2004-10-14
AU2004226262A1 (en)	2004-10-14

Legal Events

Date	Code	Title	Description
2010-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE441715T1 (de)	2009-09-15	Streptococcus pyogenes antigene
WO2004092209A3 (en)	2004-12-09	S. pneumoniae antigens
WO2005103073A3 (en)	2006-03-02	Td antigens
WO2004099242A3 (en)	2005-06-16	Streptococcus agalactiae antigens i + ii
ZA200800555B (en)	2009-09-30	IL-1² binding antibodies and fragments thereof
ATE554107T1 (de)	2012-05-15	Als therapeutika geeignete monovalente antikörperfragmente
WO2002062850A3 (en)	2003-02-20	Hybrid antibodies and uses thereof
IN2009KN02655A (de)	2015-10-23
WO2007022520A3 (en)	2007-05-10	Antibody-mediated enhancement of immune response
DK1706424T3 (da)	2009-11-02	FC-region varianter
BRPI0411854A (pt)	2006-08-29	veìculos protéicos para vacinas
WO2004074455A3 (en)	2005-02-17	Fc REGION VARIANTS
NO20054836L (no)	2005-10-19	Nogo-reseptorbindingsprotein
WO2002075274A3 (fr)	2003-12-11	Methode et trousse pour le suivi des maladies neurodegeneratives
WO2004106367A3 (en)	2005-06-16	Enterococcus antigens
WO2004029072A3 (en)	2005-12-15	PrPsc -INTERACTING MOLECULES AND USES THEREOF
DE602004024179D1 (de)	2009-12-31	Staphylococcus epidermidis antigene
WO2004094467A3 (en)	2007-02-22	H. pylori antigens
WO2004046314A3 (en)	2004-10-07	Methods for detecting asymmetric dimethylarginine in a biological sample
ATE477274T1 (de)	2010-08-15	Gegen clostridium difficile gerichtete antikörper
WO2001066752A3 (en)	2002-07-11	Reproduction-specific genes
WO2004113374A3 (en)	2005-07-14	Chlamydia pneumoniae antigens
DE60235223D1 (de)	2010-03-18	Streptococcus pyogenes polypeptide und entsprechende dna fragmente
WO2007011776A3 (en)	2007-06-21	Pamps, pathogen associated molecular patterns
CY1117395T1 (el)	2017-04-26	Il-1βητα δεσμευτικα αντισωματα και θραυσματα αυτων